{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:06:42Z","timestamp":1791986802906,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms4393","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T07:45:10Z","timestamp":1393400710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":145,"title":["Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers"],"prefix":"10.1038","volume":"5","author":[{"given":"Shingo","family":"Nakahata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonaga","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phudit","family":"Maneesaay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawin","family":"Manachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issay","family":"Kitabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Taki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyonari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Taniwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"BFncomms4393_CR1","first-page":"4644s","volume":"45","author":"K Takatsuki","year":"1985","unstructured":"Takatsuki, K. et al. Clinical diversity in adult T-cell leukemia-lymphoma. Cancer Res. 45, 4644s\u20134645s (1985).","journal-title":"Cancer Res."},{"key":"BFncomms4393_CR2","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti, F. A., Carneiro-Proietti, A. B., Catalan-Soares, B. C. & Murphy, E. L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24, 6058\u20136068 (2005).","journal-title":"Oncogene"},{"key":"BFncomms4393_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/rmv.548","volume":"17","author":"J Yasunaga","year":"2007","unstructured":"Yasunaga, J. & Matsuoka, M. Leukaemogenic mechanism of human T-cell leukaemia virus type I. Rev. Med. Virol. 17, 301\u2013311 (2007).","journal-title":"Rev. Med. Virol."},{"key":"BFncomms4393_CR4","doi-asserted-by":"publisher","first-page":"15213","DOI":"10.1073\/pnas.0507184102","volume":"102","author":"R Fukuda","year":"2005","unstructured":"Fukuda, R. et al. Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia\/lymphoma (ATLL). Proc. Natl Acad. Sci. USA 102, 15213\u201315218 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms4393_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.leukres.2006.08.001","volume":"31","author":"T Ikezoe","year":"2007","unstructured":"Ikezoe, T. et al. Longitudinal inhibition of PI3K\/Akt\/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk. Res. 31, 673\u2013682 (2007).","journal-title":"Leuk. Res."},{"key":"BFncomms4393_CR6","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943\u20131947 (1997).","journal-title":"Science"},{"key":"BFncomms4393_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng0497-356","volume":"15","author":"PA Steck","year":"1997","unstructured":"Steck, P. A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356\u2013362 (1997).","journal-title":"Nat. Genet."},{"key":"BFncomms4393_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrc3037","volume":"11","author":"MC Hollander","year":"2011","unstructured":"Hollander, M. C., Blumenthal, G. M. & Dennis, P. A. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat. Rev. Cancer 11, 289\u2013301 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms4393_CR9","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1093\/jnci\/91.22.1922","volume":"91","author":"IU Ali","year":"1999","unstructured":"Ali, I. U., Schriml, L. M. & Dean, M. Mutational spectra of PTEN\/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J. Natl Cancer Inst. 91, 1922\u20131932 (1999).","journal-title":"J. Natl Cancer Inst."},{"key":"BFncomms4393_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc1819","volume":"6","author":"M Cully","year":"2006","unstructured":"Cully, M., You, H., Levine, A. J. & Mak, T. W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184\u2013192 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms4393_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3330","volume":"13","author":"MS Song","year":"2012","unstructured":"Song, M. S., Salmena, L. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283\u2013296 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFncomms4393_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cell.2006.11.040","volume":"128","author":"LC Trotman","year":"2007","unstructured":"Trotman, L. C. et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128, 141\u2013156 (2007).","journal-title":"Cell"},{"key":"BFncomms4393_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cell.2006.11.039","volume":"128","author":"X Wang","year":"2007","unstructured":"Wang, X. et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128, 129\u2013139 (2007).","journal-title":"Cell"},{"key":"BFncomms4393_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ncb2240","volume":"13","author":"S Maddika","year":"2002","unstructured":"Maddika, S. et al. WWP2 is an E3 ubiquitin ligase for PTEN. Nat. Cell Biol. 13, 728\u2013733 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFncomms4393_CR15","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1128\/MCB.20.14.5010-5018.2000","volume":"20","author":"F Vazquez","year":"2000","unstructured":"Vazquez, F., Ramaswamy, S., Nakamura, N. & Sellers, W. R. Phosphorylation of the PTEN tail regulates protein stability and function. Mol. Cell Biol. 20, 5010\u20135018 (2000).","journal-title":"Mol. Cell Biol."},{"key":"BFncomms4393_CR16","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1073\/pnas.0510570103","volume":"103","author":"F Vazquez","year":"2006","unstructured":"Vazquez, F. et al. Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proc. Natl Acad. Sci. USA 103, 3633\u20133638 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms4393_CR17","doi-asserted-by":"publisher","first-page":"23306","DOI":"10.1074\/jbc.M611240200","volume":"282","author":"L Odriozola","year":"2007","unstructured":"Odriozola, L., Singh, G., Hoang, T. & Chan, A. M. Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J. Biol. Chem. 282, 23306\u201323315 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4393_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1073\/pnas.0811212106","volume":"106","author":"M Rahdar","year":"2009","unstructured":"Rahdar, M. et al. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc. Natl Acad. Sci. USA 106, 480\u2013485 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms4393_CR19","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1172\/JCI34616","volume":"118","author":"A Silva","year":"2008","unstructured":"Silva, A. et al. PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability. J. Clin. Invest. 118, 3762\u20133774 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFncomms4393_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clinre.2012.03.002","volume":"37","author":"Z Yang","year":"2013","unstructured":"Yang, Z. et al. Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: A novel mechanism of PTEN inactivation. Clin. Res. Hepatol. Gastroenterol. 37, 72\u201379 (2013).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"BFncomms4393_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1074\/jbc.M009134200","volume":"276","author":"J Torres","year":"2001","unstructured":"Torres, J. & Pulido, R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276, 993\u2013998 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4393_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood-2008-01-131185","volume":"112","author":"T Hidaka","year":"2008","unstructured":"Hidaka, T. et al. Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia\/lymphoma. Blood 112, 383\u2013393 (2008).","journal-title":"Blood"},{"key":"BFncomms4393_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(02)00596-7","volume":"192","author":"NC Popescu","year":"2003","unstructured":"Popescu, N. C. Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett. 192, 1\u201317 (2003).","journal-title":"Cancer Lett."},{"key":"BFncomms4393_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1745-7270.2008.00434.x","volume":"40","author":"L Yao","year":"2008","unstructured":"Yao, L., Zhang, J. & Liu, X. NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim. Biophys. Sin. (Shanghai) 40, 625\u2013635 (2008).","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"BFncomms4393_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nyas.12038","volume":"1280","author":"S Fernandes","year":"2013","unstructured":"Fernandes, S., Iyer, S. & Kerr, W. G. Role of SHIP1 in cancer and mucosal inflammation. Ann. NY Acad. Sci. 1280, 6\u201310 (2013).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFncomms4393_CR26","doi-asserted-by":"publisher","first-page":"35195","DOI":"10.1074\/jbc.M503045200","volume":"280","author":"AM Al-Khouri","year":"2005","unstructured":"Al-Khouri, A. M., Ma, Y., Togo, S. H., Williams, S. & Mustelin, T. Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta. J. Biol. Chem. 280, 35195\u201335202 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4393_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/A:1017934810825","volume":"229","author":"X Qu","year":"2002","unstructured":"Qu, X. et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol. Cell. Biochem. 229, 35\u201344 (2002).","journal-title":"Mol. Cell. Biochem."},{"key":"BFncomms4393_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/bj2560283","volume":"256","author":"C Bialojan","year":"1988","unstructured":"Bialojan, C. & Takai, A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases, specificity and kinetics. Biochem. J. 256, 283\u2013290 (1988).","journal-title":"Biochem. J."},{"key":"BFncomms4393_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00441-005-0137-5","volume":"325","author":"XL Hu","year":"2006","unstructured":"Hu, X. L. et al. Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues. Cell Tissue Res. 325, 67\u201376 (2006).","journal-title":"Cell Tissue Res."},{"key":"BFncomms4393_CR30","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1158\/0008-5472.CAN-07-5040","volume":"68","author":"DC Lee","year":"2008","unstructured":"Lee, D. C. et al. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res. 68, 4210\u20134220 (2008).","journal-title":"Cancer Res."},{"key":"BFncomms4393_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10620-012-2393-z","volume":"58","author":"X Chang","year":"2013","unstructured":"Chang, X. et al. DNA methylation of NDRG2 in gastric cancer and its clinical significance. Dig. Dis. Sci. 58, 715\u2013723 (2013).","journal-title":"Dig. Dis. Sci."},{"key":"BFncomms4393_CR32","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.bbrc.2009.12.156","volume":"391","author":"H Furuta","year":"2010","unstructured":"Furuta, H. et al. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma. Biochem. Biophys. Res. Commun. 391, 1785\u20131791 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFncomms4393_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1034\/j.1600-0714.2002.310504.x","volume":"31","author":"A Mavros","year":"2002","unstructured":"Mavros, A. et al. Infrequent genetic alterations of the tumor suppressor gene PTEN\/MMAC1 in squamous cell carcinoma of the oral cavity. J. Oral Pathol. Med. 31, 270\u2013276 (2002).","journal-title":"J. Oral Pathol. Med."},{"key":"BFncomms4393_CR34","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/j.1349-7006.2006.00343.x","volume":"97","author":"K Kozaki","year":"2006","unstructured":"Kozaki, K. et al. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma. Cancer Sci. 97, 1351\u20131358 (2006).","journal-title":"Cancer Sci."},{"key":"BFncomms4393_CR35","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1038\/onc.2008.243","volume":"27","author":"NR Leslie","year":"2008","unstructured":"Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L. & Downes, C. P. Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 27, 5464\u20135476 (2008).","journal-title":"Oncogene"},{"key":"BFncomms4393_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0014-5793(02)03274-X","volume":"528","author":"SJ Miller","year":"2002","unstructured":"Miller, S. J., Lou, D. Y., Seldin, D. C., Lane, W. S. & Neel, B. G. Direct identification of PTEN phosphorylation sites. FEBS Lett. 528, 145\u2013153 (2002).","journal-title":"FEBS Lett."},{"key":"BFncomms4393_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0006-8993(02)03366-8","volume":"954","author":"N Omori","year":"2002","unstructured":"Omori, N. et al. Enhanced phosphorylation of PTEN in rat brain after transient middle cerebral artery occlusion. Brain. Res. 954, 317\u2013322 (2002).","journal-title":"Brain. Res."},{"key":"BFncomms4393_CR38","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1038\/sj.emboj.7601118","volume":"25","author":"K Ning","year":"2006","unstructured":"Ning, K. et al. A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic beta-cells. EMBO J. 25, 2377\u20132387 (2006).","journal-title":"EMBO J."},{"key":"BFncomms4393_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1042\/BJ20061837","volume":"405","author":"H Maccario","year":"2007","unstructured":"Maccario, H., Perera, N. M., Davidson, L., Downes, C. P. & Leslie, N. R. PTEN is destabilized by phosphorylation on Thr366. Biochem. J. 405, 439\u2013444 (2007).","journal-title":"Biochem. J."},{"key":"BFncomms4393_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000113765","volume":"21","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells. Cell. Physiol. Biochem. 21, 239\u2013250 (2008).","journal-title":"Cell. Physiol. Biochem."},{"key":"BFncomms4393_CR41","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.yexcr.2010.02.028","volume":"316","author":"J Liu","year":"2010","unstructured":"Liu, J. et al. HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells. Exp. Cell Res. 316, 1985\u20131993 (2010).","journal-title":"Exp. Cell Res."},{"key":"BFncomms4393_CR42","doi-asserted-by":"publisher","first-page":"18623","DOI":"10.1074\/jbc.M401504200","volume":"279","author":"JG Burchfield","year":"2004","unstructured":"Burchfield, J. G. et al. Akt mediates insulin-stimulated phosphorylation of Ndrg2: evidence for cross-talk with protein kinase C theta. J. Biol. Chem. 279, 18623\u201318632 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4393_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1042\/BJ20041057","volume":"384","author":"JT Murray","year":"2004","unstructured":"Murray, J. T. et al. Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochem. J. 384, 477\u2013488 (2004).","journal-title":"Biochem. J."},{"key":"BFncomms4393_CR44","first-page":"1","volume":"1795","author":"PJ Eichhorn","year":"2009","unstructured":"Eichhorn, P. J., Creyghton, M. P. & Bernards, R. Protein phosphatase 2A regulatory subunits and cancer. Biochim. Biophys. Acta 1795, 1\u201315 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncomms4393_CR45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.molcel.2011.02.007","volume":"41","author":"JT Rodgers","year":"2011","unstructured":"Rodgers, J. T., Vogel, R. O. & Puigserver, P. Clk2 and B56\u03b2 mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt. Mol. Cell 41, 471\u2013479 (2011).","journal-title":"Mol. Cell"},{"key":"BFncomms4393_CR46","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1046\/j.1365-2141.2003.04452.x","volume":"122","author":"JW Cheong","year":"2003","unstructured":"Cheong, J. W. et al. Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome. Br. J. Haematol. 122, 454\u2013456 (2003).","journal-title":"Br. J. Haematol."},{"key":"BFncomms4393_CR47","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jsbmb.2006.08.006","volume":"103","author":"KA Kov\u00e1cs","year":"2007","unstructured":"Kov\u00e1cs, K. A. et al. Phosphorylation of PTEN (phosphatase and tensin homologue deleted on chromosome ten) protein is enhanced in human fibromyomatous uteri. J. Steroid Biochem. Mol. Biol 103, 196\u2013199 (2007).","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"BFncomms4393_CR48","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","volume":"265","author":"EA Lusis","year":"2005","unstructured":"Lusis, E. A. et al. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res. 265, 7121\u20137126 (2005).","journal-title":"Cancer Res."},{"key":"BFncomms4393_CR49","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/ijc.23705","volume":"123","author":"M Tepel","year":"2008","unstructured":"Tepel, M. et al. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. Int. J. Cancer 123, 2080\u20132086 (2008).","journal-title":"Int. J. Cancer"},{"key":"BFncomms4393_CR50","doi-asserted-by":"crossref","unstructured":"Piepoli, A. et al. Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour. BMC Med. Genomics 2, doi:10.1186\/1755-8794-2-11 (2009).","DOI":"10.1186\/1755-8794-2-11"},{"key":"BFncomms4393_CR51","doi-asserted-by":"publisher","first-page":"E174","DOI":"10.1210\/jc.2012-2993","volume":"98","author":"O Barreau","year":"2013","unstructured":"Barreau, O. et al. Identification of a CpG island methylator phenotype in adrenocortical carcinomas. J Clin. Endocrinol. Metab. 98, E174\u2013E184 (2013).","journal-title":"J Clin. Endocrinol. Metab."},{"key":"BFncomms4393_CR52","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/carcin\/bgp072","volume":"30","author":"A Kim","year":"2009","unstructured":"Kim, A. et al. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis 30, 927\u2013936 (2009).","journal-title":"Carcinogenesis"},{"key":"BFncomms4393_CR53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.bbrc.2007.08.195","volume":"363","author":"Y Park","year":"2007","unstructured":"Park, Y. et al. SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. Biochem. Biophys. Res. Commun. 363, 361\u2013367 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFncomms4393_CR54","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/leu.2011.379","volume":"26","author":"S Nakahata","year":"2012","unstructured":"Nakahata, S. et al. Clinical significance of CADM1\/TSLC1\/IgSF4 expression in adult T-cell leukemia\/lymphoma. Leukemia 26, 1238\u20131246 (2012).","journal-title":"Leukemia"},{"key":"BFncomms4393_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nbd.2004.01.003","volume":"16","author":"C Mitchelmore","year":"2004","unstructured":"Mitchelmore, C. et al. NDRG2: a novel Alzheimer's disease associated protein. Neurobiol. Dis. 16, 48\u201358 (2004).","journal-title":"Neurobiol. Dis."},{"key":"BFncomms4393_CR56","doi-asserted-by":"publisher","first-page":"16089","DOI":"10.1074\/jbc.272.26.16089","volume":"272","author":"M Kobayashi","year":"1997","unstructured":"Kobayashi, M. et al. Expression of a constitutively active phosphatidylinositol 3-kinase induces process formation in rat PC12 cells. Use of Cre\/loxP recombination system. J. Biol. Chem. 272, 16089\u201316092 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4393_CR57","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1038\/sj.onc.1205432","volume":"21","author":"K Sugiyama","year":"2002","unstructured":"Sugiyama, K. et al. Aurora-B associated protein phosphatases as negative regulators of kinase activation. Oncogene 21, 3103\u20133111 (2002).","journal-title":"Oncogene"},{"key":"BFncomms4393_CR58","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/abio.1993.1458","volume":"214","author":"T Yagi","year":"1993","unstructured":"Yagi, T. et al. A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214, 70\u201376 (1993).","journal-title":"Anal. Biochem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms4393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms4393","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms4393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:50:17Z","timestamp":1672959017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms4393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,5,20]]}},"alternative-id":["BFncomms4393"],"URL":"https:\/\/doi.org\/10.1038\/ncomms4393","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718288649.793492793","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]},"assertion":[{"value":"7 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3393"}}